Try our Advanced Search for more refined results
IPI Legacy Liquidation Co.
Case Number:
8:23-bk-80016
Court:
Nature of Suit:
Firms
- Baker Botts
- Balch & Bingham
- Bracewell LLP
- Chipman Brown
- Gray Reed
- Honigman LLP
- Kane Russell
- Liechty & McGinnis
- McGuireWoods
- Miller Nash LLP
- Sidley Austin
- Sullivan & Cromwell
Companies
Sectors & Industries:
-
April 01, 2024
Pharma Co. Impel's Ch. 11 Liquidation Plan Approved
Migraine-drug maker Impel Pharmaceuticals received confirmation of its Chapter 11 liquidation plan on Monday after selling its assets and making changes to the plan's exculpation provisions in response to a U.S. trustee objection.
-
February 01, 2024
Bankrupt Pharma Co. Impel Gets OK For $17.5M Sale
Migraine-drug maker Impel Pharmaceuticals can proceed with its sale to JN Bidco LLC, which had made a $17.5 million stalking horse bid, U.S. Bankruptcy Judge Stacey G. Jernigan said at a hearing Thursday in a Texas bankruptcy court.
-
December 20, 2023
Pharma Co. Impel Hits Ch. 11 With $127M Debt And Sale Plans
Migraine-drug maker Impel Pharmaceuticals Inc. and one of its subsidiaries filed for bankruptcy in Texas, listing $126.9 million in debt and plans to sell itself as a going concern.